Interest in slowing the pace of ageing has intensified over recent years, driven by a growing understanding that how old a person feels and functions does not always align with the number of years they have lived.

This gap, often described as the difference between chronological age and biological age, has become a major focus for scientists seeking ways to extend not only lifespan but healthspan.

New evidence now suggests that a simple and widely used intervention, the daily multivitamin, may play a modest role in slowing biological ageing, particularly among older adults.

Biological ageing refers to the gradual decline in cellular and physiological function over time. Unlike chronological age, it can be influenced by lifestyle, environmental exposures, and underlying health conditions. Researchers increasingly rely on biomarkers to measure this process, including so‑called epigenetic clocks. These clocks analyse chemical changes to DNA, known as DNA methylation, which accumulate with age and are linked to disease risk and mortality.

A recent large‑scale randomised clinical trial COSMOS, published in the peer‑reviewed journal Nature Medicine, adds a new dimension to this field. The study examined whether taking a daily multivitamin could influence biological ageing as measured by several established epigenetic clocks.

The findings suggest that consistent multivitamin use over two years was associated with a small but statistically significant slowing of biological ageing in older adults.

The research was embedded within a long‑running prevention trial conducted in the United States. Thousands of generally healthy men aged 60 and above and women aged 65 and above were randomly assigned to different intervention groups. Participants received either a daily multivitamin, a cocoa extract supplement, a combination of both, or placebo tablets. The trial design allowed scientists to isolate the effects of the multivitamin itself while controlling for other factors.

The multivitamin used in the study was a standard broad‑spectrum formulation commonly available to consumers. It contained essential vitamins such as A, C, D, E, and K, alongside B‑group vitamins and minerals including zinc, magnesium, calcium, and selenium. Doses were largely aligned with recommended daily intakes rather than high or “mega” doses often promoted in the supplement market.

Blood samples collected at baseline and after two years enabled researchers to assess changes in biological ageing using five different epigenetic clocks. These clocks do not measure the same aspects of ageing. Some are more closely associated with disease risk and mortality, while others focus on the pace of ageing across multiple organ systems.

At the end of the study period, two of the five clocks showed a clear benefit among participants taking the multivitamin. These were newer, second‑generation clocks that have been designed to better predict health outcomes. Compared with the placebo group, individuals taking the multivitamin experienced a slower increase in biological age, equivalent to approximately three to five months over the two‑year period.

The remaining clocks showed no significant differences between groups. This mixed result is important. It suggests that multivitamins do not uniformly affect all biological ageing measures and that their impact may be specific to certain ageing pathways captured by more advanced tools.

Researchers emphasised that biological ageing continued in all groups, including those taking supplements. The key finding was not a reversal of ageing but a reduction in the rate at which it progressed. While the numerical difference may appear small, experts note that even modest shifts at a population level could have meaningful implications for public health if linked to reduced disease risk.

One of the most striking observations emerged when scientists looked more closely at individual responses. Participants whose biological age was higher than their chronological age at the start of the trial appeared to benefit the most from the multivitamin. In other words, people ageing faster than expected showed greater slowing of biological ageing when taking the supplement.

This finding hints at a potential role for multivitamins in addressing nutritional gaps or physiological stress that contribute to accelerated ageing. Older adults with chronic conditions, suboptimal diets, or reduced nutrient absorption may be particularly vulnerable to deficiencies that affect cellular health. For these individuals, a broad‑based supplement could offer targeted support.

Experts involved in ageing research describe the results as encouraging but caution against over‑interpretation. Epigenetic clocks are powerful research tools, yet they remain surrogate markers. Slowing a clock does not automatically translate into fewer heart attacks, less dementia, or longer life. Those outcomes require long‑term follow‑up and direct measurement.

For years, patients have asked whether taking a multivitamin is worthwhile, especially when they already eat reasonably well. Evidence has been inconsistent, with many studies showing little benefit for disease prevention in well‑nourished adults.

This trial, however, provides high‑quality data suggesting a measurable biological effect, at least in older populations.

Still, cautious optimism prevails. Ageing is a complex, multi‑layered process shaped by genetics, behaviour, social factors, and environment. No single pill is likely to counteract all of these influences. Multivitamins may be one piece of a much larger puzzle.

Researchers involved in the trial highlight several priorities for future work. Long‑term tracking of participants will be crucial to determine whether changes in epigenetic ageing predict meaningful health outcomes. Additional studies could also test different formulations to identify which nutrients, or combinations, drive the observed effects. Replication in more diverse populations is another key step, as most large trials have historically under‑represented certain ethnic and socio‑economic groups.

Experts generally emphasise that supplements should not replace healthy eating. Whole foods provide a complex mix of vitamins, minerals, fibre, and bioactive compounds that work together in ways supplements cannot fully replicate. Diets consistently linked with healthier ageing, such as the Mediterranean pattern, emphasise vegetables, fruits, legumes, whole grains, nuts, fish, and olive oil. These foods deliver many of the same nutrients found in multivitamins, along with antioxidants and anti‑inflammatory compounds.

For those considering a multivitamin, quality matters. We recommend choosing products that have undergone independent third‑party testing to verify ingredient content and purity. Excessively high doses should raise red flags, as more is not always better and can sometimes be harmful. Life stage also matters. Older adults may need higher amounts of certain nutrients, such as vitamin B12 or vitamin D, due to changes in absorption and metabolism. Always consult your healthcare professionals before taking any health supplements.

The broader message emerging from this research is one of balance. A daily multivitamin appears safe, accessible, and potentially beneficial for older adults, particularly those at risk of accelerated biological ageing. Yet it works best as part of a wider strategy. Physical activity, balanced nutrition, adequate sleep, stress management, and avoidance of smoking remain foundational pillars of healthy ageing.

Scientists continue to explore how lifestyle and pharmacological interventions interact with the biology of ageing. Epigenetics offers a promising window into these processes, allowing researchers to detect subtle changes long before disease develops. As tools become more refined, they may help identify who benefits most from specific interventions and when to introduce them.

For now, the idea that a common supplement could modestly slow aspects of biological ageing adds an intriguing chapter to the ageing story. It does not promise youth in a tablet. It does, however, reinforce the notion that small, consistent choices may shape how the body ages at a cellular level.

In a field often dominated by futuristic therapies and complex technologies, the appeal of a simple daily habit is hard to ignore.